These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
757 related articles for article (PubMed ID: 28302001)
1. Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria. Gunsar F Exp Clin Transplant; 2017 Mar; 15(Suppl 2):59-64. PubMed ID: 28302001 [TBL] [Abstract][Full Text] [Related]
2. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma. Na GH; Kim EY; Hong TH; You YK; Kim DG HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857 [TBL] [Abstract][Full Text] [Related]
3. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization. Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436 [TBL] [Abstract][Full Text] [Related]
4. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation. Sharr WW; Chan SC; Lo CM Transplantation; 2014 Apr; 97 Suppl 8():S10-7. PubMed ID: 24849822 [TBL] [Abstract][Full Text] [Related]
5. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria). Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601 [TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review. Xu DW; Wan P; Xia Q World J Gastroenterol; 2016 Mar; 22(12):3325-34. PubMed ID: 27022214 [TBL] [Abstract][Full Text] [Related]
7. Effect of Downstaging and Bridging of Hepatocellular Carcinoma on Survival Following Liver Transplant: A Single Center Experience. Al Sebayel MI; Elsiesy H; Al-Hamoudi W; Alabbad S; ElSheikh Y; Elbeshbeshy H; Salih I; Yousif S; Saleh Y; Eldali A; Abaalkhail FA Exp Clin Transplant; 2017 Mar; 15(Suppl 2):7-11. PubMed ID: 28301992 [TBL] [Abstract][Full Text] [Related]
8. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. Kim Y; Stahl CC; Makramalla A; Olowokure OO; Ristagno RL; Dhar VK; Schoech MR; Chadalavada S; Latif T; Kharofa J; Bari K; Shah SA Surgery; 2017 Dec; 162(6):1250-1258. PubMed ID: 29033224 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria. Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria. Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620 [TBL] [Abstract][Full Text] [Related]
11. Living donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7 years. Uchiyama H; Itoh S; Yoshizumi T; Ikegami T; Harimoto N; Soejima Y; Harada N; Morita K; Toshima T; Motomura T; Maehara Y HPB (Oxford); 2017 Dec; 19(12):1082-1090. PubMed ID: 28888776 [TBL] [Abstract][Full Text] [Related]
12. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience. Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821 [TBL] [Abstract][Full Text] [Related]
14. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474 [TBL] [Abstract][Full Text] [Related]
15. Current surgical treatment strategies for hepatocellular carcinoma in North America. Khan AS; Fowler KJ; Chapman WC World J Gastroenterol; 2014 Nov; 20(41):15007-17. PubMed ID: 25386049 [TBL] [Abstract][Full Text] [Related]
16. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience. Lee KW; Yi NJ; Suh KS Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825 [TBL] [Abstract][Full Text] [Related]
17. Downstaging hepatocellular carcinoma: A systematic review and pooled analysis. Parikh ND; Waljee AK; Singal AG Liver Transpl; 2015 Sep; 21(9):1142-52. PubMed ID: 25981135 [TBL] [Abstract][Full Text] [Related]
18. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program. Nemes B; Gelley F; Piros L; Zádori G; Görög D; Fehérvári I; Kóbori L; Sárváry E; Nagy P; Kiss A; Doros A Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108 [TBL] [Abstract][Full Text] [Related]
19. Expanded Criteria for Hepatocellular Carcinoma in Liver Transplant. Haberal M; Akdur A; Moray G; Arslan G; Özçay F; Selçuk H; Özdemir H Exp Clin Transplant; 2017 Mar; 15(Suppl 2):55-58. PubMed ID: 28302000 [TBL] [Abstract][Full Text] [Related]
20. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial. Mazzaferro V; Citterio D; Bhoori S; Bongini M; Miceli R; De Carlis L; Colledan M; Salizzoni M; Romagnoli R; Antonelli B; Vivarelli M; Tisone G; Rossi M; Gruttadauria S; Di Sandro S; De Carlis R; Lucà MG; De Giorgio M; Mirabella S; Belli L; Fagiuoli S; Martini S; Iavarone M; Svegliati Baroni G; Angelico M; Ginanni Corradini S; Volpes R; Mariani L; Regalia E; Flores M; Droz Dit Busset M; Sposito C Lancet Oncol; 2020 Jul; 21(7):947-956. PubMed ID: 32615109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]